{"id":105988,"date":"2023-08-02T17:25:30","date_gmt":"2023-08-02T11:55:30","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=105988"},"modified":"2023-08-02T17:25:32","modified_gmt":"2023-08-02T11:55:32","slug":"pharma-stock-falls-7-after-announcing-merger-with-its-subsidiary-company","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-falls-7-after-announcing-merger-with-its-subsidiary-company\/","title":{"rendered":"Pharma stock falls 7% after announcing merger with its subsidiary company"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2252366683\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>Shares of a pharmaceutical company dropped 7.5 percent lower to reach an intraday low of \u20b9 443.85 apiece after it announced the merger of a subsidiary with itself. The company\u2019s shares settled at \u20b9 446.25 apiece on the National Stock Exchange (NSE).&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2711531680\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>The Board of Directors of <strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/STAR\/consolidated\" target=\"_blank\" rel=\"noreferrer noopener\">Strides Pharma Science<\/a><\/strong> have approved the scheme of amalgamation for the merger of Vivimed Life Sciences Private Limited (\u201cVLSPL\u201d), a wholly-owned subsidiary, with the company.\u00a0<\/p><p>The scheme was initially approved by the board at their meeting held on February 10, 2022. However, the company did not proceed with the merger at that time. It is now subject to the approval of the shareholders and regulators.&nbsp;<\/p><p>The company is looking to combine the Contract Development and Manufacturing Organization (CDMO) interests of the group which means consolidating the promoter-run injectable CDMO business under Strides into one platform. The business includes biologicals, complex injectables, and oral technologies such as drug delivery systems.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-3075700187\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>This merger is expected to simplify the group structure by consolidating similar entities with similar functions within the group. Moreover, it will result in operational and administrative efficiencies, optimum utilization of infrastructure facilities and resources, reduction in costs through focused operational efforts, rationalization, standardization and simplification of business processes and elimination of duplication.&nbsp;<\/p><p>There is no cash consideration involved. Moreover, there will not be any change in the shareholding pattern of the company\u2019s shares, as the said amalgamation is of wholly-owned subsidiary with Strides, and does not involve the issue of shares as consideration to the shareholders of Vivimed Life Sciences.&nbsp;<\/p><p>The Bengaluru headquartered company witnessed a narrower net loss of \u20b9 7.1 crore in the June quarter this year (Q1FY24), as compared to \u20b9 136 crores in the corresponding quarter last year. It reported an exceptional loss of \u20b9 6 crores in the latest quarter and of \u20b9 66 crore in the corresponding quarter last year.&nbsp;<\/p><p>Its revenue was flat at \u20b9 930 crore, which is a 1.1 percent drop from the same quarter last year. However, the company\u2019s operating performance remained strong. Its EBITDA expanded to \u20b9 166.5 crore in the latest quarter, as compared to \u20b9 60 crores in the June quarter last year.&nbsp;<\/p><p>With a market capitalization of \u20b9 4,337 crores, Strides Pharma is a small-cap company. It has a negative return on equity of 9.68 percent. Its shares were trading at a price-to-earnings ratio (P\/E) of 24.47, which is lower than the industry P\/E of 26.14, indicating that the stock might be overvalued as compared to its peers.<\/p><p>Retail investors hold a 30.85 percent stake in the company, followed by 28.07 percent by promoters, 16.67 percent by foreign institutions, 13.86 percent by mutual funds and 4.55 percent by other domestic institutions.&nbsp;<\/p><div class=\"trade-content-10\" id=\"trade-4016693072\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Simran Bafna&nbsp;<\/strong><\/p><\/blockquote><h4 class=\"wp-block-heading\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h4><div class=\"wp-block-image\"><figure class=\"aligncenter size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer.png\" alt=\"\" class=\"wp-image-26306\" width=\"256\" height=\"256\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.<\/strong><\/p><div class=\"trade-after-content\" id=\"trade-2380917083\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>Shares of a pharmaceutical company dropped 7.5 percent lower to reach an intraday low of \u20b9 443.85 apiece after it announced the merger of a subsidiary with itself. The company\u2019s shares settled at \u20b9 446.25 apiece on the National Stock Exchange (NSE).&nbsp; The Board of Directors of Strides Pharma Science have approved the scheme of [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":98971,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[948,936,10503,10505,10502,10504],"class_list":["post-105988","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-stock-market","tag-stock-market-news","tag-strides-pharma-latest-news","tag-strides-pharma-merger-with-its-subsidary","tag-strides-pharma-share-price","tag-why-is-strides-pharma-share-falling"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock falls 7% after announcing merger with its subsidiary company - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"Shares of a pharmaceutical company dropped 7.5 percent lower to reach an intraday low of \u20b9 443.85 apiece after it announced the merger of a subsidiary with itself. The company\u2019s shares settled at \u20b9 446.25 apiece on the National Stock Exchange (NSE).\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-falls-7-after-announcing-merger-with-its-subsidiary-company\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock falls 7% after announcing merger with its subsidiary company\" \/>\n<meta property=\"og:description\" content=\"Shares of a pharmaceutical company dropped 7.5 percent lower to reach an intraday low of \u20b9 443.85 apiece after it announced the merger of a subsidiary with itself. The company\u2019s shares settled at \u20b9 446.25 apiece on the National Stock Exchange (NSE).\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-falls-7-after-announcing-merger-with-its-subsidiary-company\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-02T11:55:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-02T11:55:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-falls-7-after-announcing-merger-with-its-subsidiary-company\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-falls-7-after-announcing-merger-with-its-subsidiary-company\/\",\"name\":\"Pharma stock falls 7% after announcing merger with its subsidiary company - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-falls-7-after-announcing-merger-with-its-subsidiary-company\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-falls-7-after-announcing-merger-with-its-subsidiary-company\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"datePublished\":\"2023-08-02T11:55:30+00:00\",\"dateModified\":\"2023-08-02T11:55:32+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"Shares of a pharmaceutical company dropped 7.5 percent lower to reach an intraday low of \u20b9 443.85 apiece after it announced the merger of a subsidiary with itself. The company\u2019s shares settled at \u20b9 446.25 apiece on the National Stock Exchange (NSE).\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-falls-7-after-announcing-merger-with-its-subsidiary-company\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-falls-7-after-announcing-merger-with-its-subsidiary-company\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-falls-7-after-announcing-merger-with-its-subsidiary-company\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-falls-7-after-announcing-merger-with-its-subsidiary-company\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock falls 7% after announcing merger with its subsidiary company\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock falls 7% after announcing merger with its subsidiary company - Trade Brains Features","description":"Shares of a pharmaceutical company dropped 7.5 percent lower to reach an intraday low of \u20b9 443.85 apiece after it announced the merger of a subsidiary with itself. The company\u2019s shares settled at \u20b9 446.25 apiece on the National Stock Exchange (NSE).\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-falls-7-after-announcing-merger-with-its-subsidiary-company\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock falls 7% after announcing merger with its subsidiary company","og_description":"Shares of a pharmaceutical company dropped 7.5 percent lower to reach an intraday low of \u20b9 443.85 apiece after it announced the merger of a subsidiary with itself. The company\u2019s shares settled at \u20b9 446.25 apiece on the National Stock Exchange (NSE).\u00a0","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-falls-7-after-announcing-merger-with-its-subsidiary-company\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2023-08-02T11:55:30+00:00","article_modified_time":"2023-08-02T11:55:32+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-falls-7-after-announcing-merger-with-its-subsidiary-company\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-falls-7-after-announcing-merger-with-its-subsidiary-company\/","name":"Pharma stock falls 7% after announcing merger with its subsidiary company - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-falls-7-after-announcing-merger-with-its-subsidiary-company\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-falls-7-after-announcing-merger-with-its-subsidiary-company\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","datePublished":"2023-08-02T11:55:30+00:00","dateModified":"2023-08-02T11:55:32+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"Shares of a pharmaceutical company dropped 7.5 percent lower to reach an intraday low of \u20b9 443.85 apiece after it announced the merger of a subsidiary with itself. The company\u2019s shares settled at \u20b9 446.25 apiece on the National Stock Exchange (NSE).\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-falls-7-after-announcing-merger-with-its-subsidiary-company\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-falls-7-after-announcing-merger-with-its-subsidiary-company\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-falls-7-after-announcing-merger-with-its-subsidiary-company\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-falls-7-after-announcing-merger-with-its-subsidiary-company\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock falls 7% after announcing merger with its subsidiary company"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/105988","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=105988"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/105988\/revisions"}],"predecessor-version":[{"id":105996,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/105988\/revisions\/105996"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/98971"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=105988"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=105988"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=105988"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}